Skip to main content
. 2022 Sep 25;12(10):1371. doi: 10.3390/biom12101371

Table 1.

Detailed information regarding the three selected studies matching our study criteria.

SRA Title Samples Included in Our Study Main Findings
SRP273719 Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy 42 samples (HS skin lesion pre-TNF = 19: HS skin lesion mild-moderate HS = 7: healthy skin control = 16) Highly enriched pathways in HS lesioned skin are immune related. Signatures of complement activation, B cell signaling, and pathways involving phagocytosis were found to be unique to HS. TNF-α–regulated genes, IFN-γ, and IL-1β were selected as the major drivers of the inflammatory pathways in HS skin lesions. Nonetheless, IL-1 receptor antagonist, IL-1RN, and IL-10RA, 2 potent immunoregulatory molecules, were relatively reduced in HS skin. Alongside, α-catenin and sirtuin 1, both important for regulation of cell proliferation and survival, were reduced in HS skin.
SRP272659 Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis 32 samples (HS skin lesion = 22: healthy skin control = 10) Several upregulated genes in the skin were associated with B cell responses, including immunoglobulin genes such as IGLV3-27, CD19, and CD79a. Other important genes found were the antimicrobial gene DEFB4A; CXCL13, a B cell chemoattractant, and the neutrophil chemokine CXCL1. In summary, they found B cells, and in particular plasma cells, as a potential therapeutic target in HS.
SRP168930 The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction 7 samples (HS skin lesion = 3: healthy skin control = 4) IL-1β is highly active in HS, contributing to local and systemic inflammation. IL-1β induces expression of many molecules involved in extracellular matrix destruction including MMPs, ADAM12, serpinA1, COL3A1, and COL10A1, and immune cell infiltration such as CXCL1, CXCL6, CCL7, CXCL10, CXCL16, CXCL13, CCL24, CCL2, CCL8, and CCL20. IL-1β and, therefore, MMP1, MMP3, MMP9, MMP10, CCL2, CXCL1, IL-6, and IL-32 were upregulated when compared with healthy control skin and psoriasis lesions.